7-4788272-A-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014855.3(AP5Z1):c.1573A>G(p.Lys525Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,592,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K525Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 48Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014855.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AP5Z1 | NM_014855.3 | MANE Select | c.1573A>G | p.Lys525Glu | missense | Exon 12 of 17 | NP_055670.1 | ||
| AP5Z1 | NM_001364858.1 | c.1105A>G | p.Lys369Glu | missense | Exon 11 of 16 | NP_001351787.1 | |||
| AP5Z1 | NR_157345.1 | n.1704A>G | non_coding_transcript_exon | Exon 12 of 17 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AP5Z1 | ENST00000649063.2 | MANE Select | c.1573A>G | p.Lys525Glu | missense | Exon 12 of 17 | ENSP00000497815.1 | ||
| AP5Z1 | ENST00000650581.1 | c.373A>G | p.Lys125Glu | missense | Exon 3 of 7 | ENSP00000497156.1 | |||
| AP5Z1 | ENST00000469614.1 | TSL:2 | n.47A>G | non_coding_transcript_exon | Exon 1 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 151976Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000236 AC: 5AN: 212254 AF XY: 0.0000259 show subpopulations
GnomAD4 exome AF: 0.00000556 AC: 8AN: 1440028Hom.: 0 Cov.: 31 AF XY: 0.00000420 AC XY: 3AN XY: 714514 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000855 AC: 13AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74222 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: AP5Z1 c.1573A>G (p.Lys525Glu) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 212254 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1573A>G in individuals affected with Hereditary Spastic Paraplegia 48 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at